Honoraria/Payment

Payment. We will pay you $200 for every certolizumab pegol patient and $50 for each control patient who enrolls in the study.

Rules for Payment. An enrolled patient is one who signs the informed consent and completes the follow-up NDB enrollment interview satisfactorily. If the patient decides at the time of the interview that he or she does not want to participate, we will pay you 1/4th of the above amounts ($50/$15) in compensation for your work. A non-enrolling patient may be replaced.

Enrollment failure. Enrollment failure usually occurs because the study was not carefully explained to the patient. So please take the time to go through the study with the patient, explain its purpose, and explain what the patient will have to do.

W-9 Form. Please complete this IRS W9 Form so that we may process your payment.